Boyle Kevin S. Sr.
- SEC CIK
- 0001880600
No open-market purchases or sales filed in the past year.
Current role at each company
- TCRT Alaunos Therapeutics, Inc.Chief Executive Officeras of Sep 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boyle Kevin S. Sr. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 (view filing)5:34 PM ET | Sep 1 | 4 days | Boyle Kevin S. Sr.Chief Executive Officer | SSale | −68.0K | $0.1403 | −$9.54K | −7.9%798.2K after | 10b5-1 |
| Nov 17, 2021 (view filing) | Nov 16-17 | 1 day | Boyle Kevin S. Sr.Chief Executive Officer | PPurchase | +10.0K | $1.40 | +$14.0K | +1.1%885.0K after | 2 lots |